Company record · KROS
Keros Therapeutics, Inc.
Keros Therapeutics, Inc.'s interim chief financial officer on the record is Annita Tanini, effective August 4, 2026, per the filing record.
Tracked changes
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.